Maravai Lifesciences Holdings (MRVI) Tax Provisions (2020 - 2026)

Maravai Lifesciences Holdings' Tax Provisions history runs 7 years deep, the most recent figure standing at -$151000.0 for Q1 2026.

• In Q1 2026, Tax Provisions fell 193.21% year-over-year to -$151000.0; the TTM figure through Mar 2026 stood at -$4.5 million (down 129.81% YoY), while the FY2025 annual figure was -$4.2 million, down 126.45% from the prior year.
• Tax Provisions for Q1 2026 stood at -$151000.0, down from $6000.0 in the prior quarter.
• The five-year high for Tax Provisions was $766.2 million in Q4 2023, with the low at -$5.5 million in Q3 2023.
• The 5-year median for Tax Provisions is $6000.0 (2025), against an average of $47.7 million.
• The sharpest annual moves came in 2023 and 2026: Tax Provisions surged 8970.3% in 2023, then slumped 193.21% in 2026.
• Maravai Lifesciences Holdings' Tax Provisions stood at $8.4 million in 2022, then soared by 8970.3% to $766.2 million in 2023, then tumbled by 100.0% to -$7000.0 in 2024, then surged by 185.71% to $6000.0 in 2025, then slumped by 2616.67% to -$151000.0 in 2026.
• Business Quant data shows MRVI's Tax Provisions at -$151000.0 in Q1 2026, $6000.0 in Q4 2025, and -$92000.0 in Q3 2025.